Bank Sinarmas Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Bank Sinarmas Tbk trades at Rp695 (market cap 13.56T), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B). The key difference: Bank Sinarmas Tbk is far larger — about 81× Brigit Biofarmaka Teknologi Tbk.'s market cap. Which is the better fit depends on your goals.
| BSIM | OBAT | |
|---|---|---|
Market Cap | 13.56T | 167.37B |
Indicative Equilibrium Price | 690 | 246 |
Indicative Equilibrium Volume | 1 | 24 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bank Sinarmas (the company) was established under its original name of PT Bank Shinta Indonesia base on notarial deed No.52 of Mr Buniarti Tjandra, S.H, dated on 18 Aug, 1989. The Company’s articles of association has been amended several times, most recently by notarial deed No.31 of Sutjipto, S.H., dated Apr 6 2010, concerning among others, change in par value, the name of the company, and public offering.
Read more on BSIM →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →